title: Patent news.
authors.affiliation: Thomson Current Patents, Middlesex House, 34-42 Cleveland Street, London W1T 4JE, UK. peter.steele@current-patents.com
authors.forename: Peter
authors.initials: P
authors.lastname: Steele
authors.forename: Matthew
authors.initials: M
authors.lastname: Sparrowhawk
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001549:Benzamides; D002227:Carbazoles / Q000627:therapeutic use; D004345:Drug Industry / Q000639:trends*; D012968:Etidronic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D005764:Gastroesophageal Reflux / Q000188:drug therapy; D006801:Humans; D000068877:Imatinib Mesylate; D010330:Patents as Topic; D010879:Piperazines / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D000068296:Risedronic Acid; D017366:Serotonin Receptor Agonists / Q000627:therapeutic use; D014363:Tryptamines; D006113:United Kingdom
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D002227:Carbazoles; D010879:Piperazines; D011743:Pyrimidines; D017366:Serotonin Receptor Agonists; D014363:Tryptamines; D000068877:Imatinib Mesylate; C108128:frovatriptan; D000068296:Risedronic Acid; D012968:Etidronic Acid